Foundation Medicine Priced, Nasdaq: FMI
Offers diagnostic cancer analyses that provide patient specific data for physicians.
Industry: Health Care
First Day Return: +96.4%
FMI
Offers diagnostic cancer analyses that provide patient specific data for physicians.
| IPO Data | |
|---|---|
| IPO Date | 09/24/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $106 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 2009 |
| Employees at IPO | 142 |
| Website www.foundationmedicine.com | |
IPO News for Foundation Medicine
Foundation Medicine (FMI) Performance
